Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 88, Issue -, Pages 1-11Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2018.08.001
Keywords
Insulin-degrading enzyme; Hepatic insulin resistance; Insulin receptor; Carcinoembryonic antigen-related cell adhesion molecule 1
Categories
Funding
- Ministerio de Economia, Industria y Competitividad [SAF2014-58702-C2-1-R, SAF2016-77871-C2-1-R, SAF2014-58702-C2-2-R, SAF2016-77871-C2-2-R]
- EFSD European Research Programme on New Targets for Type 2 Diabetes
- MSD
- National Institutes of Health [R01-DK054254, R01-DK083850, R01-HL-112248, R01-GM115617]
- American Diabetes Association [7-11-CD-13]
Ask authors/readers for more resources
The role of insulin-degrading enzyme (IDE), a metalloprotease with high affinity for insulin, in insulin clearance remains poorly understood. OBJECTIVE: This study aimed to clarify whether IDE is a major mediator of insulin clearance, and to define its role in the etiology of hepatic insulin resistance. Methods: We generated mice with liver-specific deletion of Ide (L-IDE-KO) and assessed insulin clearance and action. Results: L-IDE-KO mice exhibited higher (similar to 20%) fasting and non-fasting plasma glucose levels, glucose intolerance and insulin resistance. This phenotype was associated with similar to 30% lower plasma membrane insulin receptor levels in liver, as well as similar to 55% reduction in insulin-stimulated phosphorylation of the insulin receptor, and its downstream signaling molecules, AKT1 and AKT2 (reduced by similar to 40%). In addition, FoxO1 was aberrantly distributed in cellular nuclei, in parallel with up-regulation of the gluconeogenic genes Pck1 and C6pc. Surprisingly, L-IDE-KO mice showed similar plasma insulin levels and hepatic insulin clearance as control mice, despite reduced phosphorylation of the carcinoembryonic antigen-related cell adhesion molecule 1, which upon its insulin-stimulated phosphorylation, promotes receptor-mediated insulin uptake to be degraded. Conclusion: IDE is not a rate-limiting regulator of plasma insulin levels in vivo. (C) 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available